|The EIF2S3 eif2s3 (Catalog #MBS9223178) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The EIF2S3 eif2s3 product has the following accession number(s) (GI #729816) (NCBI Accession #P41091.3) (Uniprot Accession #P41091). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
eIF-2 functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S preinitiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex. In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B.
Blood, Brain, Liver, Lung, Muscle, Testis tissues are correlated with this protein. Breast Neoplasms, Disorders of Sex Development, Neurobehavioral Manifestations, Urogenital Abnormalities are some of the diseases may be linked to EIF2S3 Antibody (C-term) Blocking Peptide. The following patways have been known to be associated with this gene.